Connect Commercial Models to Improve Decision-Making in the Pharma AI Era

Pharma commercial organizations are facing a fundamental shift. Fragmented data, evolving regulations and rising expectations from healthcare professionals are making traditional, one‑size‑fits‑all engagement increasingly ineffective. At the same time, AI offers new opportunities to deliver more relevant, compliant and coordinated interactions, if used responsibly.

This webinar explores how pharma leaders are transforming commercial operations through AI‑enabled, connected engagement models that align medical, marketing and sales functions around shared insights. Rather than focusing on personalization alone, the session will examine how data foundations, governance and workflow integration enable sustainable commercial transformation.

Attendees will learn how advanced analytics and AI are being applied to customer insights, content orchestration and field execution, while ensuring compliance with global regulatory standards. The featured speaker will discuss how organizations are moving beyond fragmented systems toward unified engagement models that improve consistency, transparency and effectiveness across channels.

The session will also address key challenges, including data privacy, regulatory oversight and organizational change management. Practical examples will illustrate how commercial teams are embedding compliance into AI‑driven decision‑making, reducing operational friction and improving collaboration across functions.

This webinar is designed for leaders seeking to modernize commercial engagement in a way that builds trust, improves execution and supports long‑term growth in a highly regulated environment.

Register to learn how connected, AI‑enabled commercial models are reshaping pharma engagement, without compromising compliance.

Speaker

Eunice Youhanna, Global Commercial Pharma Lead, Microsoft

Eunice Youhanna is the Worldwide Pharma Commercial Lead at Microsoft, where she partners with global pharmaceutical organizations to drive responsible, AI‑enabled transformation across the commercial lifecycle. She advises senior leaders on applying enterprise‑grade AI to modernize workflows, unlock insights from complex data and scale innovation while maintaining trust, compliance and patient impact.

With expertise spanning pharmaceutical commercialization, artificial intelligence and strategic advisory, Eunice works across field sales, marketing, medical affairs, regulatory and market access. She is a frequent industry speaker at forums such as Pharma USA and DIA, where she focuses on pragmatic AI adoption in regulated environments and the future of human‑led, AI‑enabled pharma organizations. Based in Canada, Eunice brings a global perspective to advancing inclusive, innovation‑driven growth in life sciences.

Message Presenter